1. Home
  2. SPHR vs TLX Comparison

SPHR vs TLX Comparison

Compare SPHR & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere Entertainment Co.

SPHR

Sphere Entertainment Co.

HOLD

Current Price

$96.67

Market Cap

3.4B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.72

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPHR
TLX
Founded
2020
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SPHR
TLX
Price
$96.67
$7.72
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$85.67
$21.00
AVG Volume (30 Days)
735.4K
176.1K
Earning Date
03-02-2026
01-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$1,075,530,000.00
$664,225,558.00
Revenue This Year
$14.51
N/A
Revenue Next Year
$10.26
N/A
P/E Ratio
N/A
$181.75
Revenue Growth
N/A
55.35
52 Week Low
$23.89
$7.16
52 Week High
$101.89
$30.36

Technical Indicators

Market Signals
Indicator
SPHR
TLX
Relative Strength Index (RSI) 56.95 46.25
Support Level $95.31 $7.16
Resistance Level $100.22 $8.45
Average True Range (ATR) 3.90 0.22
MACD -0.48 0.11
Stochastic Oscillator 52.65 42.92

Price Performance

Historical Comparison
SPHR
TLX

About SPHR Sphere Entertainment Co.

Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: